FDA Files

FDA Files

Posted FDA letters and notices, with the actual document linked. Primary records only.

Documented records

FDA FILEDOCUMENTED
FDA tells five peptide sellers “research use only” labels do not exempt their injectables

DOCUMENTED. FDA posted warning letters on Sept. 1, 2026 (dated Aug. 24) to five peptide sellers, stating that products sold as “research use only” are unapproved new drugs. The letters are FDA’s allegations; each firm was told to respond within 15 business days.

Observed 2026-09-01 · Published 2026-10-05
FDA FILEREPORTED
FDA advisory panel backs six of seven peptides, including BPC-157, for the compounding list

REPORTED. FDA’s page confirms a July 23-24, 2026 advisory committee meeting on seven peptides; outlets report the panel supported six of them (including BPC-157) for the 503A bulks list and rejected one. The votes are nonbinding and a formal rule would be needed before pharmacies could compound them.

Observed 2026-07-24 · Published 2026-10-05
FDA FILEDOCUMENTED
FDA sends warning letters to five peptide sellers that also offered bacteriostatic water

DOCUMENTED. FDA posted warning letters on Apr. 7, 2026 (dated Mar. 31) to five peptide sellers, citing unapproved new drug violations; all five letters also name bacteriostatic water sold alongside the peptides. The letters are FDA’s allegations; each firm had 15 working days to respond.

Observed 2026-04-07 · Published 2026-10-05
FDA FILEDOCUMENTED
FDA sends warning letters to four research-peptide sellers over semaglutide and retatrutide products

DOCUMENTED. FDA posted warning letters on Dec. 17, 2024 (dated Dec. 10) to four online sellers of research peptides, saying their semaglutide, retatrutide and related products are unapproved new drugs. The letters are FDA’s allegations; each firm had 15 working days to respond.

Observed 2024-12-17 · Published 2026-10-05

Mentioned in the wire

Status note: This item includes industry discussion, public posts, or submitted tips. It is not an allegation of wrongdoing and should not be treated as verified fact unless specifically marked Documented or Confirmed.